Security: Series C Preferred
Location: Cranbury, NJ

CEO: Ron Burch
CFO: Jeff Rona

New Investors: Advent International, S.R. One, Pacific Rim, Index Ventures, Lehman Brothers, Hunt Ventures, EGS Healthcare Capital, Piper Jaffray, NIF, Axiom, Cogene BioTech, William Harris Investors
Existing Investors: JP Morgan Partners, InterWest Partners, Sofinnova Ventures

Board of Directors: Ron Burch, Charlie Cohen, Rod Ferguson, Arnie Oronsky, Mike Powell

- AlgoRx is a pharmaceutical company focused on the development of pain management products that address areas of unmet need.

- The round of financing received over $100 million of interest, and the deal size increased from $30 million due to demand.

- Aquilo served as exclusive placement agent, owning and driving the transaction process to a close.

- In 2005, AlgoRx merged with Corgentech to form public company Anesiva (NASDAQ: ANSV) .